M&A related to immuno-oncology in the global pharmaceutical industry (by deal value) - Q4 2020 – Q1 2023
Value in $m
Q4
2020
Q1
2021
Q2
Q3
Q4
Q1
2022
Q2
Q3
Q4
Q1
2023
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
Deal value
GlobalData